Sinopharm umbrella will guarantee rapid IP applications. That is certainly a difference between ours and their system, once backed by the right channels, progress in IP protection is a much faster affair.
I would therefore not stress about those hurdles.
A positive CACLP outcome will pave the way for quick commercialisation IMO.
Ann: Anteo Makes Solid Progress With Geneodx Partnership, page-39
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
